Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD ...Middle East

GOTHENBURG, Sweden, March 17, 2026 /PRNewswire/ -- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the Swedish Medical Products Agency...

Hence then, the article about cereno scientific receives approval to initiate fda aligned phase i pharmacokinetic study of cs014 supporting phase ii development in ph ild was published today ( Tuesday 17/03/2026 - 02:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD )

Also on site :

• En medio de la crisis, el Gobierno de Cuba anuncia reformas económicas aunque persisten los obstáculos
• LA28 ticket registration nears deadline as first Olympic qualifiers emerge
• What do you need to vote in Illinois? What you can take into the ballot box with you